TRIB3 and urinary bladder carcinoma: Liang et al. (2019) indicated that FKBP10 may be a potential therapeutic target for the treatment of gastric cancer via bioinformatics analysis and immunohistochemical verification. Yang et al. (2021) confirmed that TRIB3 was a potential prognostic marker and therapeutic target for bladder cancer through bioinformatics analysis and cell function experiment.